Age group I 20 - 34 (n = 133) | Age group II 35 - 39 (n = 133) | Age group III 40 - 42 (n = 78) | Age group IV 43 - 47 (n = 42) | P Value | |
Unilateral tubal occlusion (%) | 18 | 14.3 | 16.7 | 4.8 | 0.2 |
Bilateral tubal occlusion (%) | 13.5 | 12.8 | 25.6 | 21.4 | 0.054 |
Pelvic adhesions (%) | 13 | 9 | 24.4 | 9.5 | 0.005 |
Male factor (%) | 81 | 66.9 | 53.8 | 64.3 | 0.308 |
Unexplained infertility (%) | 28 | 17.3 | 20.5 | 23.8 | 0.778 |
Endometriosis (%) | 14 | 6.8 | 6.4 | 7.1 | 0.63 |
Menstrual length (days ± STD) | 36.46 ± 30.36 | 29.69 ± 14.26 | 28.17 ± 2.03 | 29.48 ± 11.31 | 0.026 |
FSH (IU/ml ± STD) | 8.998 ± 7.046 | 9.637 ± 5.11 | 10.938 ± 6.201 | 10.274 ± 5.311 | 0.006 |
Prolactinng/ml | 16.57 ± 8.667 | 17.26 ± 10.854 | 13.69 ± 7.683 | 16.83 ± 3.369 | 0.028 |
TSH (IU/ml ± STD) | 2.21 ± 1.242 | 2 ± 1.074 | 2.33 ± 0.921 | 2.93 ± 1.701 | 0.002 |
POR in the past % | 30.8 | 43.6 | 53.8 | 38.1 | 0.016 |